Description of the Course: 

Autoimmune diseases are a major cause of morbidity, and their incidence and prevalence continue to rise. HSCT has evolved for >20 years as a specific treatment of patients with severe autoimmune disease, through eradication of the pathologic, immunologic memory and profound immune ‘resetting’. This course will cover all important aspects of HSCT in relation to the pathophysiology and therapy of autoimmune diseases, including current and future indications, immunological mechanisms and novel targets. It brings together most of the world’s leading experts, actively contributing to the evidence base and professional guidelines in the field. The ultimate goal of this e-learning is to support the EBMT ADWP's objective of improving the care of patients receiving HSCT for Autoimmune Diseases.

Learning Objectives: 

• Understand basic concepts in stem cell transplatnation for autoimmune diseases, including indications, graft source, and regimen intensity. 
• Increase knowledge on outcomes of HSCT in most relevant indications compared to best available conventional and bologic therapies. 
• Recognize possible complications of the transplant procedure and basic treatement principles.

Modules: 

There are three modules plus an evaluation: 

• Stat-of-the art 
• Transplant regimens, mechanisms, and complications 
• Recommended reading
• Evaluation

The evaluation must be completed with a minimum passing grade of 75% to obtain a certificate and a post-evaluation survey is also required by all participants. 

How to Access the Course:

EBMT Online Learning Course for Autoimmune Diseases is available on the e-learning platform and currently open for EBMT members.

The estimated time to do this course is four hours.

To access the course and its content, click the enroll button below.